Epidemiological studies of anti-obesity medicines depict short-term success, but long-term contraindication and failure. The health and fitness industry demonstrates an exponential increase in banned or withdrawn medicines. Everyone is in pursuit of the ``golden bullet''. How effective are the older prescription medicines such as orlistat? History has demonstrated retrospectively that the ``fen-phen'' prescriptive phenomenon cost countless lives and billions of dollars in compensation. New medicines and lower doses of older failed medications to combat the obesity pandemic are being researched. A complete re-assessment of what is available and what is worthwhile is required.
|Title of host publication||Chemically Modified Bodies|
|Subtitle of host publication||The Use of Diverse Substances for Appearance Enhancement|
|Editors||Matthew Hall, Sarah Grogan, Brendan Gough|
|Place of Publication||London|
|Publisher||Palgrave Macmillan US|
|Number of pages||27|
|Publication status||Published - 2016|